ArticleFrontiers in cellular and infection microbiology2026
Epidemiological characteristics of bacterial lower respiratory tract infections in Jingzhou, Central China, 2020-2024.
Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Lower respiratory tract infections (LRTIs) represent a significant global public health issue and impose a substantial disease burden. However, regional epidemiological surveillance data on bacterial LRTIs in central China remain insufficient. This study aimed to systematically analyze the epidemiological characteristics of patients with bacterial LRTIs in Jingzhou, Hubei Province, China. Methods: This study included 5,442 hospitalized patients diagnosed with LRTIs between January 2020 and December 2024. Detection of respiratory pathogens was performed both using a chip-based loop-mediated isothermal amplification (LAMP) assay and the standard culture method (SCM). The LAMP assay kit simultaneously detects ten predefined bacterial respiratory pathogens, including Results: Among 5,442 samples, the overall positive rate of LAMP was 31.86%, with single-pathogen infections accounting for 26.17%. Conclusion: These findings demonstrate significant age-related and temporal variations in the pathogen spectrum of bacterial LRTIs and provide epidemiological evidence to support empirical antibacterial decision-making and population-targeted prevention strategies. In addition, LAMP may serve as a practical molecular diagnostic tool for rapid bacterial pathogen detection, although its clinical utility in primary healthcare settings warrants further investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.